Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To investigate the efficacy and safety of repurposed antiprotozoal and antiretroviral drugs, nitazoxanide and atazanavir/ritonavir, in shortening the time to clinical improvement and achievement of SARS-CoV-2 polymerase chain reaction (PCR) negativity in patients diagnosed with moderate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Trials
Autori principali: Olagunju, Adeniyi, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez, Adeagbo, Babatunde Ayodeji, Onayade, Adedeji, Bolaji, Oluseye Oladotun, Happi, Christian, Rannard, Steve, Owen, Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Letter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780204/
https://ncbi.nlm.nih.gov/pubmed/33397457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04987-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi